MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: Central Serous Chorioretinopathy
MedXY News
EnglishTag

Central Serous Chorioretinopathy

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationcritical carebiomarkersartificial intelligencetype 1 diabetesclinical trialsHypertensiononcologyCardiologyMortalitypublic healthcardiovascular diseasediabetesAlzheimer's diseasebreast cancerepidemiology

Latest news

Tag

Predicting Central Serous Chorioretinopathy Outcomes Using Interpretable AI-Driven OCT Biomarkers: Insights from a Multicenter Cohort Study
SuperintelligenceCentral Serous Chorioretinopathy光学干渉断層撮影

Predicting Central Serous Chorioretinopathy Outcomes Using Interpretable AI-Driven OCT Biomarkers: Insights from a Multicenter Cohort Study

By MedXY|Oct 21, 2026

A multicenter study demonstrates that interpretable machine learning applied to baseline OCT biomarkers accurately predicts chronicity in central serous chorioretinopathy, facilitating early risk stratification and personalized management.

Unraveling Mid-phase Hyperfluorescent Plaques in Central Serous Chorioretinopathy: Insights from Multimodal Imaging
news
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Central Serous Chorioretinopathy
Indocyanine green angiography

Unraveling Mid-phase Hyperfluorescent Plaques in Central Serous Chorioretinopathy: Insights from Multimodal Imaging

By MedXY|Oct 8, 2026

This study elucidates the dynamic nature and structural correlates of mid-phase hyperfluorescent plaques on ICGA in CSCR, highlighting their progression stages and OCT features that signal disease activity.

Cluster-Based Structural Phenotypes of Chronic Central Serous Chorioretinopathy: Clinical and Imaging Insights
Clinical UpdatesCentral Serous ChorioretinopathyOCT

Cluster-Based Structural Phenotypes of Chronic Central Serous Chorioretinopathy: Clinical and Imaging Insights

By MedXY|Sep 30, 2026

Unsupervised clustering defines three structural phenotypes in chronic CSC, linking photoreceptor damage with choroidal changes and visual prognosis, refining disease stratification beyond photoreceptor staging alone.

Immune-Mediated Disorders and Central Serous Chorioretinopathy: Clinical Insights from the MICRoN Report 21
Allergy & ImmunologyVisual Outcomesretinal imaging

Immune-Mediated Disorders and Central Serous Chorioretinopathy: Clinical Insights from the MICRoN Report 21

By MedXY|Aug 26, 2026

This study reveals that central serous chorioretinopathy (CSCR) in patients with immune-mediated disorders exhibits distinct clinical and imaging features, with immune-mediated status linked to poorer visual outcomes and higher recurrence,

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models